Complications of levodopa therapy in Parkinson's disease

被引:2
|
作者
Dubow, Jordan [1 ]
Olanow, C. Warren [2 ]
机构
[1] Avadel Pharmaceut PLC, Chesterfield, MO 63005 USA
[2] Mt Sinai Hlth Syst, Dept Neurol & Neurosci, New York, NY USA
来源
EXPERT OPINION ON ORPHAN DRUGS | 2019年 / 7卷 / 09期
关键词
Parkinson's disease; motor complications; dyskinesia; wearing off; levodopa; EXTENDED-RELEASE CAPSULES; CARBIDOPA INTESTINAL GEL; PLACEBO-CONTROLLED TRIAL; DEEP-BRAIN-STIMULATION; DOUBLE-BLIND; MOTOR FLUCTUATIONS; INDUCED DYSKINESIA; WEARING-OFF; DOPAMINE; ISTRADEFYLLINE;
D O I
10.1080/21678707.2019.1662294
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Levodopa remains the most effective treatment for the motor symptoms of Parkinson's disease (PD). However, with chronic treatment, PD patients develop motor complications, which consist of motor fluctuations and dyskinesia. Many new treatments, both medical and interventional, have been developed for the treatment of motor complications but there continues to be an unmet medical need for further treatments. Areas covered: This manuscript summarizes the phenomenology, pathophysiology, prevalence and current and future treatments of motor complications in PD patients based on a PubMed literature search from 1950s to present. Expert opinion: Motor complications are prevalent in PD and risk factors for developing these complications are well-known and well characterized. There are many effective medical and interventional treatments for both motor fluctuations and dyskinesia in PD patients. Despite these treatments, many patients still suffer from many hours of 'Off' time or dyskinesia that have a profound negative impact on quality of life. There are many exciting treatments under development for motor complications that may provide additional benefit for PD patients.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 50 条
  • [31] Novel Approaches to Optimization of Levodopa Therapy for Parkinson’s Disease
    Yasaman Kianirad
    Tanya Simuni
    [J]. Current Neurology and Neuroscience Reports, 2016, 16
  • [32] Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease
    Yokochi, Masayuki
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S25 - S30
  • [33] Advances in levodopa therapy for Parkinson disease
    Gupta, Suneel
    [J]. NEUROLOGY, 2016, 86 (14) : S1 - S2
  • [34] Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease
    Koziorowski, Dariusz
    Friedman, Andrzej
    [J]. MOVEMENT DISORDERS, 2007, 22 (07) : 1033 - 1036
  • [35] Liquid levodopa-carbidopa in advanced Parkinson's disease with motor complications
    Yang, Hui-Jun
    Ehm, Gwanhee
    Kim, Young Eun
    Yun, Ji Young
    Lee, Woong-Woo
    Kim, Aryun
    Kim, Han-Joon
    Jeon, Beomseok
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 377 : 6 - 11
  • [36] LEVODOPA-INDUCED MOTOR COMPLICATIONS IN VIETNAMESE PATIENTS WITH PARKINSON'S DISEASE
    Dang, T. H. T.
    Tran, N. T.
    Le, M.
    [J]. PARKINSONISM & RELATED DISORDERS, 2018, 46 : E70 - E70
  • [37] LEVODOPA-INDUCED MOTOR COMPLICATIONS IN AN INCIDENT PARKINSON'S DISEASE COHORT
    Scott, Nicholas W.
    Macleod, Angus D.
    Counsell, Carl E.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (11):
  • [38] Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease
    Antonini, Angelo
    Jost, Wolfgang H.
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2018, 86 : S5 - S9
  • [39] G2019S mutation and motor complications of levodopa in Parkinson disease
    Farhat, Nouha
    Ben Romdhane, Sawssan
    Nasri, Amina
    Hdiji, Olfa
    Sakka, Salma
    Gargouri, Amina
    Ben Djebara, Mouna
    Damak, Mariem
    Gouider, Riadh
    Mhiri, Chokri
    [J]. NEUROLOGY, 2019, 92 (15)
  • [40] Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease
    Michalowska, Malgorzata
    Chalimoniuk, Malgorzata
    Jowko, Ewa
    Przybylska, Iwona
    Langfort, Jozef
    Toczylowska, Beata
    Krygowska-Wajs, Anna
    Fiszer, Urszula
    [J]. BRAIN AND BEHAVIOR, 2020, 10 (03):